These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1860301)

  • 1. Therapy of acute thromboembolism with heparin and warfarin.
    Carter BL
    Clin Pharm; 1991 Jul; 10(7):503-18. PubMed ID: 1860301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin and warfarin therapy after acute myocardial infarction.
    Yedinak KC; Sproat TT
    Clin Pharm; 1993 Mar; 12(3):197-215. PubMed ID: 8491077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
    Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myocardial infarction and thromboembolism during pregnancy].
    Härtel D; Sorges E; Carlsson J; Römer V; Tebbe U
    Herz; 2003 May; 28(3):175-84. PubMed ID: 12756475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?
    Hull RD; Pineo GF
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():11-23. PubMed ID: 15085462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic effects of drugs used in the ICU. Anticoagulants and thrombolytics. Risks and benefits.
    Guidry JR; Raschke RA; Morkunas AR
    Crit Care Clin; 1991 Jul; 7(3):533-54. PubMed ID: 1863882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a standardized heparin nomogram to achieve therapeutic anticoagulation after thrombolytic therapy in myocardial infarction. TIMI 4 investigators. Thrombolysis in Myocardial Infarction.
    Flaker GC; Bartolozzi J; Davis V; McCabe C; Cannon CP
    Arch Intern Med; 1994 Jul; 154(13):1492-6. PubMed ID: 8018004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Nov; 157(20):2317-21. PubMed ID: 9361572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DVT and pulmonary embolism: Part II. Treatment and prevention.
    Ramzi DW; Leeper KV
    Am Fam Physician; 2004 Jun; 69(12):2841-8. PubMed ID: 15222649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts of anticoagulation therapy.
    Hull RD; Pineo GF
    Clin Chest Med; 1995 Jun; 16(2):269-80. PubMed ID: 7656539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin in pediatric patients.
    Sutor AH; Chan AK; Massicotte P
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():31-9. PubMed ID: 15085464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory pharmacology. Antithrombotic and fibrinolytic therapy.
    Watson-Williams EJ
    Clin Chest Med; 1986 Sep; 7(3):469-80. PubMed ID: 3533402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolism.
    de Swiet M
    Clin Haematol; 1985 Oct; 14(3):643-60. PubMed ID: 3907913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.